Announcements Trials
Browse Landscape

Phase

Phase 2 139Phase 1 44Phase NA 37Phase 3 24Phase 1/2 19Phase 2/3 7Phase 4 2Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 76Colorectal Neoplasms 55Carcinoma, Hepatocellular 51Stomach Neoplasms 34Colonic Neoplasms 26Breast Neoplasms 23Lung Neoplasms 15Rectal Neoplasms 12Ovarian Neoplasms 12Liver Neoplasms 12Sarcoma 11Gastrointestinal Neoplasms 11Neoplasms 10Esophageal Neoplasms 10Barrett Esophagus 9Melanoma 7Head and Neck Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Prostatic Neoplasms 6Cholangiocarcinoma 6Carcinoma, Renal Cell 5Neoplasm Metastasis 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Ductal Adenocarcinoma 3Osteosarcoma 3Esophageal Squamous Cell Carcinoma 3Disease 3Digestive System Neoplasms 3

Interventions

tremelimumab 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Adenocarcinoma Of Esophagus × Gastrointestinal × Clear all
NCT06824363 2026-01-30

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

University of California, Irvine

Phase EARLY_PHASE1 Not yet recruiting
34 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡